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Abstract
Mutation or loss of collagen VI has been linked to a variety of musculoskeletal abnormalities, particularly muscular
dystrophies, tissue ossification and/or fibrosis, and hip osteoarthritis. However, the role of collagen VI in bone and cartilage
structure and function in the knee is unknown. In this study, we examined the role of collagen VI in the morphology and
physical properties of bone and cartilage in the knee joint of Col6a1
2/2 mice by micro-computed tomography (microCT),
histology, atomic force microscopy (AFM), and scanning microphotolysis (SCAMP). Col6a1
2/2 mice showed significant
differences in trabecular bone structure, with lower bone volume, connectivity density, trabecular number, and trabecular
thickness but higher structure model index and trabecular separation compared to Col6a1
+/+ mice. Subchondral bone
thickness and mineral content increased significantly with age in Col6a1
+/+ mice, but not in Col6a1
2/2 mice. Col6a1
2/2 mice
had lower cartilage degradation scores, but developed early, severe osteophytes compared to Col6a1
+/+mice. In both
groups, cartilage roughness increased with age, but neither the frictional coefficient nor compressive modulus of the
cartilage changed with age or genotype, as measured by AFM. Cartilage diffusivity, measured via SCAMP, varied minimally
with age or genotype. The absence of type VI collagen has profound effects on knee joint structure and morphometry, yet
minimal influences on the physical properties of the cartilage. Together with previous studies showing accelerated hip
osteoarthritis in Col6a1
2/2 mice, these findings suggest different roles for collagen VI at different sites in the body,
consistent with clinical data.
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Introduction
Collagen VI is heterotrimeric protein consisting of three
different a-chains: a1(VI), a2(VI), and a3(VI). Collagen VI has
been shown to play a bridging role in connective tissues, where it
forms a flexible network interlinking collagen types I, II, IV,
proteoglycans, hyaluronan, and cells [1,2,3,4,5]. Recent research
has identified three other collagen VI subunits, a4(VI), a5(VI), and
a6(VI), which may substitute in place of a3(VI) in the
heterotrimeric fibrils [6,7]. Human collagen VI genetic abnor-
malities have been linked to muscular disorders, specifically
Bethlem myopathy, Ullrich congenital muscular dystrophy and
congenital myosclerosis [8,9,10,11], and to ligamentous disorders,
namely ossification of the ligamentum flavum, ossification of the
posterior longitudinal ligament of the spine, and diffuse idiopathic
skeletal hyperostosis [12,13,14]. Mutations in collagen VI genes
have also been linked to mitochondrial dysfunction [15], to
abnormal expression of proteoglycans and adhesion molecules in
some tissues [16,17], and to a skin disorder, atopic dermatitis [7].
Recently, a susceptibility locus for atopic dermatitis was identified
in COL6A5 [18] and the DVWA (double von Willebrand factor A
domains) susceptibility locus for knee osteoarthritis identified as
part of COL6A4 [19,20].
In addition to its important role in muscle, collagen VI is
present in most other musculoskeletal tissues. In articular cartilage,
collagen VI is normally found distinctly localized to the
pericellular matrix (PCM) [21] in conjunction with other
molecules such as collagen IX, decorin, fibronectin, and
hyaluronan, where it is believed to help anchor the chondrocyte
to the PCM [1,22,23]. In this respect, it is hypothesized that
collagen VI is critical for proper transduction of biochemical and
biomechanical signals to the cell [24,25]. In bone, collagen VI has
been identified both in remodeling bone [26] and in developing
bone, where it may play a role in bone formation at the growth
plate [27], with evidence for its role in regulating collagen I
expression in the early phase of IL-4-induced mineralization [28].
Collagen VI has also been found in other tissues of the knee,
including the synovium [29], electron-dense seams of ligaments
[30], and the cellular, pericellular, and main-body regions of the
menisci [31,32], as well as in other cartilaginous tissues such as the
intervertebral disc [33].
In mice, targeted gene disruption of Col6a1 prevents the
formation of collagen VI. Although these mice do not exhibit
any major physical abnormalities, the disruption of Col6a results in
muscular defects characteristic of Bethlem myopathy [15,34].
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2/2mice also exhibit skeletal abnormalities including
delayed development and ossification, as well as accelerated
osteoarthritic changes in the hip joint in comparison to Col6a1
+/
+controls [27]. However, clinical studies have shown that collagen
VI mutations may have significantly differing effects on proximal
versus distal joints of the body, depending on the specific mutation
[9]. For example, Bethlem myopathy is generally characterized by
proximal muscle weakness and distal joint contractures, while
Ullrich congenital muscular dystrophy is associated with proximal
joint contractures, distal hyperlaxity and global muscle weakness
[9]. As muscle weakness and joint laxity can alter joint loading and
are associated risk factors for osteoarthritis, the potential influence
of collagen VI deficiency on osteoarthritis may vary among
different joints of the body.
The goal of this study was to examine the hypothesis that the
absence of collagen VI affects the development and age-related
changes of bone and cartilage in the knee joint. The knees of
Col6a1
+/+ and Col6a1
2/2 mice were assessed by quantitative
micro-computed tomography (microCT) and histologic analysis.
The micro-scale physical properties of the articular cartilage were
determined using atomic force microscopy (AFM) to measure the
elastic modulus, roughness, and frictional coefficient of the
articular surface, and scanning microphotolysis (SCAMP) to
measure the diffusional transport properties of the cartilage.
Materials and Methods
Tissue Preparation
All studies and protocols involving animals were approved by
the Duke University Institutional Animal Care and Use Commit-
tee (registry number A137-09-05). Col6a1
+/+ and Col6a1
2/2 mice,
created by Bonaldo et al. [34], were raised on a CD1 genetic
background [27]. At the target age of 2, 9, or 15 months old
(n=8–9 mice per group, 4 males and 4 or 5 females) were
sacrificed and frozen at 220uC. The final 15-month time point
was chosen with consideration that 80% of C57BL/6J mice
survive to 24 months, and spontaneous knee arthritis occurs in
39% at age 12–17 months [35]. The earliest time point was chosen
to demonstrate a still-maturing skeleton. Although in some cases,
freezing at 220uC has been shown to alter mechanical properties
of articular cartilage [36], all samples were treated equally and
thus freezing should not affect overall outcome. The left and right
legs were isolated and thawed for dissection directly before fixation
(right limb: microCT and histology studies) or before microscopy
(left limb: AFM and diffusion studies).
Microcomputed Tomography (MicroCT)
Right knee joints were fixed in 10% buffered neutral formalin.
Knees were scanned by a microCT system (microCT 40, Scanco
Medical AG, Bassersdorf, Switzerland) using scan acquisition
parameters of 55 kV and intensity of 144 mA medium resolution
(16 mm) images were produced. A hydroxyapatite (HA) calibration
phantom was used to scale values of linear attenuation for the
calcified tissues to known density values of 100, 200, 400 and 800
HA mg/cc [37]. All segmentation and morphology measures were
performed within the Scanco software. Bone morphology was
evaluated along the long axis of the tibia in two regions, the tibial
epiphysis proximal to the growth plate and the metaphyseal region
in the 25 contiguous slices immediately distal to the fibular
attachment, as described previously [38]. In the tibial epiphysis,
the cortical and trabecular bone together were evaluated for total
volume (TV, mm
3), bone volume (BV, mm
3), bone volume
fraction (BV/TV), and bone density (BD, mg HA/cm
3), and the
trabecular bone alone was evaluated for structure model index
(SMI, a quantitative measure of the shape of the trabeculae, which
tends to increase with age and/or disease) [39,40], connectivity
density (ConnDens, 1/mm
3), trabecular number (Tb.N, 1/mm),
trabecular thickness (Tb.Th, mm), and trabecular separation
(Tb.Sp, mm). In the tibial metaphysis, bone volume (BV, mm
3)
and bone tissue density (BD, mg HA/cm
3) were evaluated for both
cortical and trabecular bone. These values were multiplied to
calculate mineral content (mg). The length of the tibial epiphysis
was estimated by counting the number of 16-mm slices from the
subchondral bone of the tibial plateau distally to the growth plate;
the lengths of two subsets of this region, the trabecular and non-
trabecular (subchondral bone) portions, were measured.
Histology
Following scanning by microCT, intact knee joints were
decalcified, dehydrated in EtOH, embedded in paraffin, and
sectioned by microtome into 7-mm coronal slices perpendicular to
the long axis of the tibial. Sections were stained with hematoxylin,
Fast Green, and safranin-O. Digital micrographs were taken of the
slides (Olympus BX41 microscope, Olympus DP-11 camera,
Olympus, Center Valley, PA).
The subchondral bone thickness was measured across the full
width of the loaded regions of the femoral condyle and tibial
plateau in histologically stained sections. These subchondral
thickness measures did not include calcified cartilage. For each
of the medial and lateral condyles and regions of the tibial plateau,
ten lines were drawn from the internal edge of the calcified
cartilage to the nearest bone marrow. Lines were equally spaced
along the subchondral bone and perpendicular to the cartilage
surface. These lengths were averaged to determine the mean
subchondral bone thickness for the joint. Additionally, the
thickness of the joint capsule was measured on the medial side
of the joint adjacent to the meniscus. This joint capsule, which
primarily included the medial collateral ligament (MCL), was
measured with five lines drawn perpendicular to the joint space
adjacent to the meniscus. Line lengths were averaged.
Three experienced, blinded graders (JMC, BDF, HAL) evaluated
histological samples to assess arthritic progression according to a
modified Mankin score for mouse knee joints, as described
previously [37]. Briefly, articular cartilage structure, tidemark
duplication, safranin-O staining, fibrocartilage, hypertrophic
chondrocytes and subchondral bone were assessed for a score of
28 points. Four sites were evaluated: the lateral femoral condyle,
lateral tibial plateau, medial femoral condyle, and medial tibial
plateau. The scores from all graders for each site were averaged
and summed to a single score ranging from 0 to 112, with higher
scores indicating greater levels of osteoarthritic joint degeneration.
Average scores for each experimental group were reported with
standard error indicated.
Three blinded graders experienced in knee joint morphology
(BDF, FG, HAL) graded the same histologic samples to asses
osteophyte development according to a grading protocol based on
previously reported histomorphological and cell biological param-
eters [41]. Osteophytes were graded based on these identified
stages of osteophyte development: in Stage I, mesenchymal
condensates and evidence of chondrogenic differentiation are
present; in Stage II, fibrocartilage develops with a mixture of
cartilaginous and fibrous matrix components; in Stage III, the
proliferating osteophyte shows a zonal organization similar to the
fetal growth plate cartilage with extensive chondrocyte hypertro-
phy in the zones adjacent to ongoing endochondral bone
formation; and in Stage IV, ‘mature’ osteophytes resemble largely
articular hyaline cartilage. Lateral and medial regions of the tibial
plateau and femoral condyles were each given a score of 0–4 for
Collagen VI in the Knee Joint
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were averaged among the graders and summed for a total
osteophyte score ranging from 0 to 16. Median scores for each
experiment group were reported with quartile indicated.
Immunohistochemistry for Collagen VI
Immunohistochemistry was performed to confirm the presence
or absence of collagen VI in the articular cartilage of the knee. An
IgG rabbit polyclonal anti-collagen VI antibody was used to bind a
peptide near the amino terminus of the murine a1(VI) chain (sc-
20649, Santa Cruz Biotechnology, CA). An Alexa FluorH 488-
conjugated secondary antibody, goat anti-rabbit IgG (Invitrogen/
Molecular Probes, Carlsbad, CA) was used for primary antibody
detection [27,42]. Samples were further incubated with ethidium
homodimer-1 (Molecular Probes, Carlsbad, CA) to stain nucleic
acids. Samples were imaged using a 1006, 1.3-NA oil-immersion
objective with differential interference contrast (DIC), an argon
laser (excitation 488 nm), and a helium laser (excitation 633 nm).
A band-pass filter (505–550 nm) and a long-pass filter (650 nm)
collected emissions from the secondary antibody and the ethidium
homodimer-1, respectively.
Atomic Force Microscopy
For AFM measurements, the left mouse tibia was thawed,
carefully dissected, and cut at mid-shaft with a razor blade to
shorten its length. Hot-melt glue (Arrow Fastener Co., Saddle
Brook, NJ) was used to secure the diaphysis of the tibia vertically
within a small polystyrene Petri dish lid (Becton Dickenson,
Franklin Lakes, NJ), leaving the tibial plateau near-horizontal
within the lid. Phosphate-buffered saline (PBS, Gibco, Carlsbad,
CA) at room temperature was added to cover the tibial plateau.
The lid was secured to a glass microscope slide and oriented such
that the anterior-posterior direction on the lateral tibial plateau
was perpendicular to the AFM cantilever.
AFM cantilever tips were constructed by gluing (Norland optical
adhesive #81, Norland Products Inc., Cranbury, NJ) 10-mm-
diameter borosilicate microspheres (Duke Scientific Corporation,
Palo Alto, CA) near the free end of a triangular silicon nitride
AFM cantilever (Veeco, Santa Barbara, CA) with a nominal spring
constant of 0.58 N/m [43]. Tips were coated with gold, ozone-
cleaned, and functionalized with a monolayer of tri-ethylene
glycol-terminated alkane thiol (SH-(CH2)11-EG3, Sigma Aldrich,
St. Louis, MO) to inhibit tip fouling during the test procedure.
Friction was measured on the lateral tibial plateaus using a
MFP-3D atomic force microscope (Asylum Research, Santa
Barbara, CA) as described previously [43]. Briefly, friction was
measured by tracking the lateral deflection signal as the probe
scanned over the surface with a scan angle of 90. The area
measured in each sample was grossly the midpoint of the lateral
plateau, away from tendons, ligaments or meniscus. Normal force
spring constants were found using the MFP-3D software provided
by Asylum Research [44] and lateral calibration constants were
calculated by the wedge method [45,46]. For three different
50650 mm cartilage areas, the probe was raster-scanned at
40 mm/s for 16 scan lines and 512 points captured per scan line.
Each area was scanned at applied normal loads increasing from 20
to 100 nN [43]. The friction forces were averaged and graphed
versus the applied normal load, after which the slope was taken as
the coefficient of friction.
Roughness was calculated from an AFM image (128 scan lines
by 128 points) of one of the friction sites on each tibia. The
50650 mm field was scanned with a 20 nN applied normal load
and a 100 mm/s scan speed. To avoid any plateau tilt effects on
these data, a first-order (linear) flattening correction was applied
and the root mean square (RMS) roughness recorded. The
flattening technique corrects for any artifacts in image acquisition
by fitting each scan line with a polynomial and subtracting it from
the raw data.
AFM indentation was used to determine the elastic modulus of
the cartilage surface via elastic tests previously described
[47,48,49]. At each of the three 50650 mm tibial plateau fields
where friction was measured, 1 mm/s indentation testing was
performed at 16 sites using a 464 layout. A sampling rate of 1 kHz
and a force trigger of 100 nN was used. The elastic modulus was
then calculated from the force vs. indentation data using a Hertz
contact model for a hard sphere against an infinite plane in which
the Poisson’s ratio for the murine cartilage was assumed to be 0.20
[50,51]. The moduli from these 16 sites were then averaged for
each 50650 mm field, leading to 3 separate values of indentation
data for each limb evaluated.
Scanning Microphotolysis (SCAMP)
SCAMP uses high laser power to simultaneously image and
photobleach a single line segment that decreases in intensity over
time as a function of the rate of photobleaching and rate of
diffusion of the fluorescent molecule of interest. The diffusion
coefficient and bleaching rate constant are determined by fitting a
3D theoretical diffusion-reaction model which accounts for the
out-of-plane bleaching effects [52]. The left mouse femur was
carefully dissected and soaked overnight in 70 kDa fluorescent
dextran (25 mg/mL) at 4uC. A razor blade was used to slice
sagittally through the lateral and medial condyles. The femur was
placed in a coverslip chamber with the sliced condyle face
positioned flush against the coverslip to allow a full-thickness view
of the cartilage via the inverted microscope. All SCAMP
experiments were performed in the extracellular matrix of the
articular cartilage middle zone of any of the sliced, exposed faces
[53].
As previously described [54], a 1006, 1.3-NA oil immersion
lens at 66 zoom on a confocal laser scanning microscope (LSM
510, Zeiss) was used to bleach a line 1.44-mm wide (12 pixels) at a
depth of 6 mm into the tissue. Bleaching was performed forward
and backward for a total of 40 passes at two simultaneous
excitation wavelengths, 458 and 488 nm. During bleaching, the
emission intensity was also collected (long-pass filter, LP505) and
stored as the image for that pass. At each site, five experiments
were performed; their intensity values were averaged and median-
filtered to minimize noise. For each test site, the experimental data
was compared to simulated datasets using an unconstrained
nonlinear optimization function; the resulting best fit established
an appropriate value for the diffusion coefficient (D), which is the
parameter of interest, and the space-dependent bleaching rate
constant (k), which is a function of laser bleaching power and so
varies with depth into the cartilage. All data processing, fits, and
simulations were performed in Matlab (The Mathworks, Natick,
MA). Diffusion coefficients were measured at 4–6 sites in each
joint and the mean value was reported.
Statistical Analyses
In Statistica (StatSoft, Tulsa, OK), each dataset was evaluated
with the Shapiro-Wilks test for normal distribution; based on those
outcomes, the non-normal elastic modulus data were log-
transformed for statistical analysis. Next, multifactorial analysis
of variance (ANOVA) was performed to assess significant
(a=0.05) main effects and interactive effects of genotype, sex,
and age. Fisher’s LSD post-hoc test was used to compare
individual results where the ANOVA established a significant
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normal data after log-transformation.
Results
Col6a1
2/2 mice did not exhibit any major phenotypic
abnormalities or show any increase in mortality at the time points
examined. Immunohistochemistry staining confirmed that colla-
gen VI was present in the PCM of Col6a1
+/+ cartilage and was
absent from Col6a1
2/2 cartilage (Figure 1); in the Col6a1
+/+tibia,
the growth plate also showed significant labeling for collagen VI
(data not shown).
Tibial Epiphysis: Trabecular Bone
In the trabecular regions of the tibial epiphysis, the total volume,
bone volume, bone volume fraction, bone tissue density,
connectivity density, SMI, trabecular number, trabecular separa-
tion, and trabecular thickness were all measured by microCT
(Table S1). The main effects of age (except total volume) and
genotype (except bone tissue density) were significant. Briefly,
morph metric values for Col6a1
2/2 mice were lower for bone
volume, bone volume fraction, connectivity density, trabecular
number, and trabecular thickness, but were higher for SMI and
trabecular separation, as compared to Col6a1
+/+.
More specifically, the SMI of Col6a1
2/2 mice reflected ‘‘rod-
like’’ structures (SMI closer to 3) from the youngest age through
maturity, whereas the Col6a1
+/+SMI indicated plate-like structures
(SMI closer to 0) that became more rod-like over time (Figure 2A).
Trabecular bone volume for Col6a1
2/2 mice remained smaller
and constant, unlike the Col6a1
+/+ trabecular bone volume which
dropped significantly with age (Figure 2B). In Col6a1
2/2 mice,
total volume values increased with age to surpass the Col6a1
+/+
values (Table S1). The connectivity density dropped significantly
with age in Col6a1
2/2 mice, whereas the Col6a1
+/+ connectivity
density remained consistently higher (Figure 2C). With skeletal
maturity (,4 months old [55]), bone tissue density increased only
4% from 2 to 9 months in Col6a1
2/2 mice, while Col6a1
+/+ bone
tissue density increased 19% (Figure 2D). MicroCT images
comparing 2-month-old Col6a1
+/+ and Col6a1
2/2 trabecular bone
are presented in Figure 3.
Tibial Epiphysis: Cortical and Trabecular Bone
Several differences were observed in the total volume, bone
volume, bone volume fraction, bone tissue density, and length of
the bone in the tibial epiphysis. The main effects of age (except
bone volume fraction) and genotype (except total volume and
length) were significant (Table S1). Length and total volume
showed increases with age that were similar for both genotypes.
Bone volume increased steadily with age for Col6a1
+/+ while the
bone volume in Col6a1
2/2 mice was lower at all time points as
compared to Col6a1
+/+ and did not increase as drastically with age
(46% vs. 23% respectively). The net result is that Col6a1
2/2 bone
volume fraction remained unchanged while Col6a1
+/+ bone
volume fraction increased (16%) between the 2 to 9 month time
points, then leveled off. With skeletal maturity (,4 months old
[55]) Col6a1
2/2 bone tissue density increased only 5% versus 21%
for Col6a1
+/+ measured between the 2 and 9 month time points.
Tibial Metaphysis: Cortical and Trabecular Bone
In the tibial metaphysis (Figures 3E and 3F), only bone volume
andbone tissuedensitywerequantifiedbymicroCT.Both showed a
statistically significant main effect of age (but not of genotype) and a
significant interactive effect of age-by-genotype (Table S1). Bone
volume did not change significantly over time in Col6a1
2/2 mice,
but Col6a1
+/+ bone volume increased 77% from 2 to 9 months. As
with metaphyseal bone volume and epiphyseal bone density,
metaphyseal bone density was influenced by skeletal maturity;
Col6a1
+/+ bone tissue density increased 34% versus 7% in Col6a1
2/
2 mice. Based on the mineral content calculated from the bone
volume and bone tissue density values in this region, the Col6a1
2/2
mice did not gain any mineral content with age, whereas the
mineral content increased nearly four-fold during skeletal matura-
tion from 2 to 9 months in Col6a1
+/+ mice (Figure 4).
Joint Capsule Thickness
From the histology images, the joint capsule thickness (primarily
the MCL) was measured adjacent to the medial meniscus and was
affected by genotype (ANOVA, p,0.02) (Figure 5a). In the
Col6a1
2/2 mice, the joint capsule was consistently thick at all ages,
whereas the Col6a1
+/+ mice had initially thin joint capsules that
thickened with age. Interestingly, most of the 9-month Col6a1
+/+
mice had a joint capsule thickness comparable to that of the 2-
month Col6a1
+/+ mice (,70 mm), yet the mean 9-month Col6a1
+/+
value was raised substantially by two very thick values (,500 mm) in
particularly degraded joints. Additionally, many of the Col6a1
2/2
joint capsules stained heavily for proteoglycan content (Figure 6),
and a few had visible ossification.
Subchondral Bone Thickness
From histology images, the mean subchondral bone thickness
per joint was calculated by averaging the subchondral thickness at
four sites: the lateral femoral condyle, the lateral tibial plateau, the
medial femoral condyle, and the medial tibial plateau. The
subchondral bone was thinner for the Col6a1
2/2 mice at all ages
but thickened markedly with age for the Col6a1
+/+ mice (p,0.02
Figure 1. Immunolabeling for collagen VI in the articular
cartilage of the mouse tibial plateau cartilage. Top row: Collagen
VI is found exclusively in the pericellular region of chondrocytes in the
wild-type PCM (left). Bottom row: Corresponding DIC images overlaid
with collagen VI labeling (green) and nuclear staining (red). Cartilage of
the Col6a1
2/2 mice (right) shows no labeling for collagen VI. Scale bar,
50 mm. WT=Col6a1
+/+;K O=Col6a1
2/2.
doi:10.1371/journal.pone.0033397.g001
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statistical significance (p,0.0002) of age, genotype, and age-by-
genotype effects (Figure 5b).
The microCT measures of subchondral bone thickness
confirmed these histology findings (Table S1). The microCT
assessment of subchondral bone did result in numerically higher
thickness measures than histologic assessment. However, the
microCT measured only subchondral bone of the tibia, and some
portion of calcified cartilage may be captured by the microCT
thickness measures.
Cartilage Degeneration
Using a modified Mankin score, the extent of cartilage
degradation was determined in the lateral femoral condyle, lateral
tibial plateau, medial femoral condyle, and medial tibial plateau of
each joint. Col6a1
2/2 mice showed delayed or reduced cartilage
degradation with age relative to the Col6a1
+/+ mice (Figure 7a).
ANOVA revealed significant effects of side (medial or lateral,
p,0.00003), but not bone (femur or tibia, p=0.13), age (p=0.06),
genotype (p=0.12) and age*genotype (p=0.15) to be significant.
In general, the cartilage showed an age-dependent increase in the
osteoarthritic degeneration score; likewise, greater degradation
was observed on the medial side of the joint as compared to the
lateral side.
Col6a1
2/2 mice also showed a significant number of osteo-
phytes (Figures 6). An osteophyte grading scheme was used to
quantify the severity of these growths. As expected, Col6a1
+/+ mice
showed age-dependent increases in osteophytes. Col6a1
2/2 mice
showed higher osteophyte scores, starting at 2 months with a
median score 8 times that of Col6a1
+/+ mice (5.7 vs 0.7,
respectively) and remaining higher; although the effect decreased
with age (Figure 7b). Nonparametric Kruskal-Wallis showed 2
month Col6a1
+/+ mice to be significantly different from Col6a1
2/2
mice at all time points.
The presence of osteophytes is generally not included in
osteoarthritic grading schemes for mice as most mouse models of
Figure 2. MicroCT measures of trabecular bone structure. In the tibial epiphysis of collagen VI null mice (Col6a1
2/2), the structure model
index (SMI, A) shows evidence of rod-like trabeculae from the earliest age, in contrast to the initially plate-like trabeculae of the wild-type mice. The
trabecular bone volume (BV, B) is low from an early age and contributes to a higher bone tissue density (BD, D) in 2-month-old Col6a1
2/2 mice. With
increasing age, the Col6a1
2/2 connectivity density (ConnDens, C) drops significantly at 15 months. Bars are mean 6 SEM. Starred bars with no
connecting lines are different from all other bars including each other. Horizontal lines connect statistically significantly different values. *p,0.05;
**p,0.01. WT=Col6a1
+/+;K O=Col6a1
2/2.
doi:10.1371/journal.pone.0033397.g002
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however, in this case, osteophyte score was combined with the
modified Mankin score to better assess the unique joint changes in
these mice. This comprehensive score showed trends similar to
that of the modified Mankin score; an age-dependent increase in
the osteoarthritic degeneration score in Col6a1
+/+ mice and stable
degeneration scores in Col6a1
2/2 mice (Figure 7c).
Friction, Roughness, Elastic Modulus, and Diffusivity
The coefficient of friction of the articular cartilage of the tibial
plateaus of the 2-month and 15-month mice ranged from 0.19 to
0.24. No statistically significant differences were observed in this
property with time or genotype (Table S2).
RMS roughness was measured on tibial plateaus of all mice
except one 15-month Col6a1
2/2 mouse, which was too rough to
scan with this AFM setup. Age significantly influenced the
roughness RMS (p,0.02), with the oldest mice having the
roughest cartilage, but no differences with genotype were observed
(Table S2).
Cartilage stiffness (elastic modulus) decreased significantly with
age (p,0.02, Table S2). Cartilage from Col6a1
2/2 joints showed a
trend for a lower elastic modulus at all age points but no
statistically significant difference was observed (p,0.09).
The diffusivity of 70 kDa dextran through the ECM of femoral
condyle cartilage averaged 13 mm
2/s and was highly variable.
Figure 3. MicroCT images of 2-month-old mouse knees, showing the calcified structures of the right knees of a male wild-type
mouse (left images: A, C, E) and a male Col6a1
2/2 mouse (right images: B, D, F). Top row (A, B) shows a medial view of the knee; note the
ossified medial collateral ligament in the Col6a1
2/2 joint (arrow, B). Middle row (C, D) displays a distal view of the tibial trabecular bone, where the
Col6a1
2/2 trabeculae are rod-like while the wild-type trabeculae are plate-like. Bottom row (E, F) shows a proximal view of the tibial metaphyseal
region, where the wild-type bone is immature in comparison to the Col6a1
2/2 bone. WT=Col6a1
+/+;K O=Col6a1
2/2.
doi:10.1371/journal.pone.0033397.g003
Figure 4. Mineral content of the Col6a1
2/2 tibial metaphysis. In
the tibial metaphysis directly distal to the fibular attachment (25
microCT slices=0.4 mm), wild-type mice quadrupled their mineral
content from 2-months-old to 9-months-old. In contrast, collagen VI
null mice already had an intermediate level of mineral content by 2
months of age; this mineral content never changed. Bars are mean 6
SEM; those sharing the same letter are not statistically different; bars
with different letters: p,0.01. WT=Col6a1
+/+;K O=Col6a1
2/2.
doi:10.1371/journal.pone.0033397.g004
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2/2
cartilage showed a trend for increased values: 17 mm
2/s (p=0.06
relative to 15-month Col6a1
2/2 data; p,0.05 relative to all other
data) (Table S2).
Discussion
The findings of this study provide new evidence of significant
skeletal abnormalities associated with the lack of collagen VI. In
particular, Col6a1
2/2 mice exhibited major differences in the
trabecular bone within the proximal tibia, yet showed limited
developmental changes in bone structure between 2 months and 9
months of age, as compared to the dramatic changes observed in
Col6a1
+/+ mice. In contrast to the hip joint [27], Col6a1
2/2 mice
showed delayed cartilage degeneration but drastically increased
and earlier osteophyte development. Measures of the physical
properties of the articular cartilage did not reveal consistent
differences between genotypes. These findings suggest that
alterations in bone structure are an early and important
characteristic of Col6a1
2/2 mice, whereas the influence of collagen
VI on the health and function of the synovial joint may depend
significantly on the specific site.
An important new observation of this study is the significant
influence that collagen VI may have on bone development and
structure. Previous studies have shown delayed skeletal develop-
ment and lower body bone mineral density in Col6a1
2/2 mice
[27]. When compared to Col6a1
+/+, the trabecular bone of
Col6a1
2/2 mice showed lower bone volume, trabecular number,
trabecular thickness, and connectivity density, but higher trabec-
ular separation and SMI. Overall, these differences reflect
trabecular bone structure with thinner, more widely spaced
trabecular struts in Col6a1
2/2 mice, consistent with other mouse
models bearing deletion or mutation of different collagen genes.
For example, mice with the collagen I mutation oim present with
fewer and thinner trabeculae in the femoral head relative to their
wild-type counterparts [56]. Col10a1
2/2 mice show an early
decrease in newly formed bony trabeculae and evidence of patchy
mineralization of trabeculae, but an overall greater trabecular
Figure 5. Effects of genotype on the joint capsule and subchondral bone. Joint capsule thickness on the medial side was high in Col6a1
2/2
mice from the youngest age but almost universally low in wild-type mice until the oldest age (A). Subchondral bone thickness, in contrast, shows that
Col6a1
2/2 bone fails to thicken with age, unlike the wild-type bone (B). Bars are mean 6 SEM. Starred bars with no connecting lines are different from
all other bars including each other. Starred bar connected by notches on horizontal line to multiple bars is different from those values. *p,0.05,
**p,0.01. WT=Col6a1
+/+;K O=Col6a1
2/2.
doi:10.1371/journal.pone.0033397.g005
Figure 6. Histologic images revealed differences among wild-
type and Col6a1
2/2 knees at 2, 9, and 15 months. Coronal tissue
slices (7 mm thick) were stained with fast green for collagen (blue) and
safranin-O for proteoglycans (proteoglycans), and Harris’ hematoxylin
for nuclei (black). The left side is lateral while the right side is medial.
The collagen VI null knees (right column) include a thick and
proteoglycan-rich medial collateral ligament, increased chondrophyte
formation on the lateral femur, larger trabeculae in both bones, and at 2
months a more confined growth-plate staining relative to the wild-type
knees (left column). Scale bar=1 mm. WT=Col6a1
+/+;K O=Col6a1
2/2.
doi:10.1371/journal.pone.0033397.g006
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mice leads to lower trabecular bone volume fraction, lower
trabecular thickness, and greater trabecular separation in the 3-
month-old lumbar vertebral bodies [58]. Mice deficient in both
Col9a1
2/2 and cartilage oligomeric matrix protein show a non-
significantly lower trabecular mineral density at 1 month of age
[59]. These previous studies, taken together with the findings of
the current study, support the important role of various collagens
in the assembly and maturation of bone.
The development and maturation of bone is highly dependent
on mechanical loading, and a number of previous studies have
shown changes in bone density and trabecular structure in
association with altered muscle loads (e.g., [60]). Given the
myopathy of Col6a1
2/2 mice [34], abnormal loading may be
present at the knee and could influence trabecular bone
characteristics. It is of interest to note that the differences between
the Col6a1
2/2 and Col6a1
+/+ trabecular bone structures closely
match the pattern of changes seen in studies of constrained
locomotor modes [61], mechanically-altered loading (e.g., [62]), or
disuse (e.g., [63]). Nonetheless, Col6a1
2/2 mice do not show
altered activity levels (C57BL/6 background, [34]). Furthermore,
our findings did not reveal characteristics of cartilage ‘‘disuse’’,
such as loss of proteoglycans from the cartilage matrix [64].
Further characterization of the biomechanical and behavioral
characteristics of these mice may provide additional insights into
the potential role of altered mechanical loads in relation to the
bone changes observed in this study.
The mineral content of the tibial metaphysis was constant
(,0.75 mg HA) at all ages in the Col6a1
2/2 mouse. That value was
intermediate to the Col6a1
+/+ mineral content, which was a low
0.31 mg at 2 months yet quadrupled with skeletal maturity to
1.15 mg at 9 and 15 months. Given previous evidence of skeletal
changes during maturation in young Col6a1
2/2 mice, including
abrupt whole-body bone mineral density (DXA) increases from 1-
month old to 3-months old [27], it is surprising to see no indication
of additional mineral deposition in the proximal tibial metaphysis
as these mice age. However, abnormalities in collagen VI, a
protein widespread in the bone growth plate, have been linked to a
variety of ossification abnormalities including reduced bone
mineral density [27], ligament ossification disorders [12,13,14],
and delayed skeletal development [27]. These studies, together
with the mineral deposition pattern observed, imply an important
role for collagen VI in bone development.
Histologic analysis showed trends of progressive cartilaginous
degeneration in the knees of CD1 Col6a1
+/+ mice, whereas the
Col6a1
2/2 mice showed lower degeneration scores at all ages.
Similarly, Col6a1
2/2 mice did not show thickening of the
subchondral bone, a typical characteristic of osteoarthritis,
whereas in the Col6a1
+/+ mice, the subchondral bone thickened
more than 4-fold. However, Col6a1
2/2 mice showed significantly
increased presence of osteophytes at the boundaries of the articular
cartilage (Figure 6), which has been previously reported following
local injection of transforming growth factor beta [65] or through
cartilage-specific activation of beta catenin [66]. In contrast to this
slower cartilage degradation pattern in Col6a1
2/2 knees, previous
study of the hip joint identified accelerated and more severe
degeneration for Col6a1
2/2 mice [27]. The disparity may be due
to apparent site-specific effects of collagen VI mutations on
connective tissue properties. For example, reduced collagen VI in
Bethlem myopathy leads to proximal hypotonia and distal joint
contractures [9,70], whereas Ullrich congenital muscular dystro-
phy can be associated with hip laxity [10]. As joint laxity is a
predisposing factor in the development of osteoarthritis (e.g.,
[71,72]), differences in joint stability arising from muscle weakness
and/or laxity may differentially influence specific joints of the
body. Alternatively, the disparity in osteoarthritis progression
between joints may be attributable to a potentially protective effect
of large osteophytes that formed at the knee. It has been postulated
that osteophytes act to stabilize the knee joint; in the knee, after a
tear of the anterior cruciate ligament which acts to restrict sagittal
movement of the tibia, osteophytes develop anteriorly and
posteriorly and limit translocation of the femur on the tibia [67].
Additionally, the removal of osteophytes from human osteoar-
thritic knees has been shown to significantly increase versa-valgus
instability [68], and in grade V disk degeneration of the spine,
osteophyte formation decreases rotational movement in flexion
and extension compared to lower grades, leading to spinal
stabilization [69].
In previous studies, the loss of PCM stiffness has been associated
with osteoarthritic changes in the joint. For example, human
osteoarthritic cartilage exhibits reduced PCM stiffness as com-
pared to non-osteoarthritic controls [73,74]. Furthermore, Co-
Figure 7. Effects of genotype on cartilage and joint structure. Cartilage degradation in Col6a1
2/2mice did not significantly increase with age,
whereas wild type cartilage increased from 2 to15 months. (A) Bars are mean 6 SEM. Osteophyte score was initially low in Col6a1
+/+ mice and trended
up with age, whereas severity of osteophytes began and remained high among the Col6a1
2/2 mice (B). Median with quartile bars shown. The
combination of the two scores showed trends similar to that of the Modified Mankin score (C). Bars are mean 6 SEM. Starred bar connected by
notches on horizontal line to multiple bars is different from those values. *p,0.05, **p,0.01. WT=Col6a1
+/+;K O=Col6a1
2/2.
doi:10.1371/journal.pone.0033397.g007
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2/2 and Col6a1
+/2 mice showed reduced PCM stiffness in the
hip at 1 month of age, preceding any apparent changes in ECM
histology or mechanical properties [27]. As the mechanical
environment of the chondrocyte plays an important role in
regulating its metabolic activity [75,76], such alterations in PCM
properties may ultimately contribute to chondrocyte dysfunction
in osteoarthritis. For example, Col9a1
2/2 mice exhibit osteoar-
thritic changes and loss of cartilage mechanical properties in the
medial compartment of the knee [77]. In the current study,
cartilage extracellular matrix stiffness did not change between
Col6a1
2/2 and Col6a1
+/2 mice, which is not surprising given that
type VI collagen is only found in the pericellular matrix. We did
not measure PCM mechanical properties in the knee, and thus it is
not possible to determine if the lack of apparent cartilage
degeneration in the knee was similarly associated with a lack of
change in the PCM, despite the absence of type VI collagen. Thus
future studies may wish to address this issue in a joint-specific
manner using techniques such as AFM indentation to determine
PCM properties [78,79].
The measures of boundary friction coefficients were highly
variable; on average, they showed no statistically significant
change with age or genotype. The coefficients (0.2160.14)
corresponded well to previous friction data collected via this
technique for 10-week-old (0.4260.19) and 20-week-old
(0.2560.11) C57BL/6J mice [43,48]. Elastic modulus values also
varied widely, although Col6a1
+/+ mice generally had a higher
modulus than Col6a1
2/2. Overall, values were markedly lower
than previously published values (10-week and 20-week C57BL/6J
mice: ,260 kPa and 3546158 kPa, respectively) [43,48]. Finally,
RMS roughness increased with age, with a trend toward rougher
cartilage surface in the oldest mice. This trend is consistent with
the progression of cartilage degradation with age, seen by
histology.
The microscale diffusion technique used in this study provides a
novel measure of macromolecular diffusivity of mouse cartilage. In
general, the coefficients of diffusion measured in the mouse
cartilage are similar to those obtained for cartilage of other species
using this technique, i.e., ,23 mm
2/s in the extracellular matrix of
porcine cartilage [53]. However, diffusion measurements revealed
limited differences with age or genotype in this study. Average
diffusive transport of 70 kDa dextran was fairly consistent at the
older ages (9 and 15 months: 13 mm
2/s), but at 2 months, the
Col6a1
2/2 had a diffusivity 55% higher than that of the Col6a1
+/+
cartilage (11 mm
2/s versus 17 mm
2/s). This finding may reflect
differences in the extracellular microstructure that may correspond
to a developmental delay [27]. Because of the high cellularity of
mouse cartilage at this age, the measurements may in fact
represent differences in the PCM diffusivity due to the lack of
collagen VI.
In conclusion, the findings of this study provide evidence of
musculoskeletal abnormalities at the knee as a consequence of
collagen VI absence. The trabecular bone characteristics reveal
distinct structural differences between Col6a1
2/2 and Col6a1
+/
+bones. The proximal metaphysis mineral content did not increase
with skeletal maturity in Col6a1
2/2; the implications of this trend
are unclear, but the cause may be altered mechanical loading due
to joint laxity or muscle weakness, or potentially dysregulation of
bone development in the absence of collagen VI. Of particular
interest was the finding of delayed osteoarthritic degeneration in
Col6a1
2/2 mice, although the physical properties of the knee
cartilage were found to be similar to those of the Col6a1
+/+ mice.
Clearly, further investigation of these parameters may provide new
insights into the influence of the diverse characteristics of collagen
VI loss or mutation on the musculoskeletal system.
Supporting Information
Table S1 MicroCT measurments of bone properties.
Bone properties were determined using microCT imaging and
analysis as shown in Figure 3. Significant differences in bone
properties were noted by genotype and age. Data are presented as
mean 6 standard deviation (n=8 samples per group except n=9
for wild-type 15 mo). *p,0.05, **p,0.01. The F-statistic is
reported for p,0.5 in order of Age, Genotype, and Age-by-
Genotype.
(XLSX)
Table S2 Biomechanical and biophysical properties of
articular cartilage. The elastic modulus, roughness, and
coefficient of friction were determined using atomic force
microscopy, and the diffusion coefficient was determined using
scanning microphotolysis. Data are presented as mean 6 standard
deviation, *p,0.05, **p,0.01. The F-statistic is included for
significant findings.
(XLSX)
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